作者投稿
专家审稿
编辑办公
邮件订阅
RSS
-
-
[1] American Cancer Society.Cancer facts & figures 2007 [R]. New York: American Cancer Society, 2007: 1-52. [2] Jemal A, Murray T, Ward E, et al.Cancer statistics, 2005 [J].CA Cancer J Clin, 2005, 55:10-30. doi: 10.3322/canjclin.55.1.10 [3] Pisters PW, Wolff RA, Crane CH, et al.Combined-modality treatment for operable pancreatic adenocarcinoma[J]. Oncology, 2005, 19: 393-404, 409 [discussion 409-410, 412-416]. [4] Yonezawa S, Higashi M, Yamada N, et al.Precursor lesions of pancreatic cancer[J].Gut Liver, 2008, 2:137- 154. doi: 10.5009/gnl.2008.2.3.137 [5] Hruban RH, Pitman MB, Klimstra DS.Tumors of the pancreas[M] //Atlas of tumor pathology.Fascicle 6. 4 th ed. Washington, DC: American Registry of Pathology and Armed Forces Institute of Pathology, 2007. [6] Klimstra DS, Longnecker DS.K-rasmutations in pancreatic ductal proliferative lesions[J].Am J Pathol, 1994, 145: 1547-1550. http://europepmc.org/articles/PMC1887515/ [7] Aimoto T, Uchida E, Nakamura Y, et al.Multicentric pancreatic intraepithelial neoplasias(PanINs) presenting with the clinical features of chronic pancreatitis[J].J Hepatobiliary Pancreat Surg, 2008, 15:549-553. doi: 10.1007/s00534-007-1269-7 [8] Sipos B, Frank S, Gress T, et al.Pancreatic in traepithelial neoplasia revisited and updated[J].Pancreatology, 2009, 9:45-54. doi: 10.1159/000178874 [9] Cubilla AL, Fitzgerald PJ.Morphological lesions associated with human primary invasive nonendocrine pancreas cancer [J].Cancer Res, 1976, 36:2690-2698. http://www.ncbi.nlm.nih.gov/pubmed/1277176 [10] Tanaka M, Chari S, Adsay NV, et al.International consensus guidelines formanagement of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas[J].Pancreatology, 2006, 6:32. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=4a02666da46e34f6258b4884ad8281d6 [11] Kern SE, Hruban RH, Hidalgo M, et al.An introduction to pancreatic adenocarcinoma genetics, pathology and therapy [J].Cancer Biol Ther, 2002, 1:607-613. doi: 10.4161/cbt.307 [12] Recavarren C, Labow DM, Liang J, et al.Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions[J].Hum Pathol, 2011, 42:18-24. doi: 10.1016/j.humpath.2010.05.022 [13] Berman JJ, Albores-Saavedra J, Bostwick D, et al.Precancer:A conceptual working definition Results of a Consensus Conference[J].Cancer Detect Prev, 2006, 30:387-394. doi: 10.1016/j.cdp.2006.09.002 [14] Fukushima N, Sato N, Ueki T, et al.Aberrant methylation of preproen kephalin and p16 genes in pancreatic intraep ithelial neoplasia and pancreatic ductal adenocarcinoma[J]. Am J Pathol, 2002, 160:1573-1581. doi: 10.1016/S0002-9440(10)61104-2 [15] Shi C, Hong SM, Lim P, et al.KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin[J].Mol Cancer Res, 2009, 7:230- 236. doi: 10.1158/1541-7786.MCR-08-0206 [16] Laghi L, Orbetegli O, Bianchi P, et al.Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and inbiliary cancers[J].Oncogene, 2002, 21:4301-4306. doi: 10.1038/sj.onc.1205533 [17] Schutte M, Hruban RH, Geradts J, et al.Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas[J].Cancer Res, 1997, 57:3126-3130. http://www.ncbi.nlm.nih.gov/pubmed/9242437 [18] Rosty C, Geradts J, Sato N, et al.p16 inactivation in pancreatic intraepithelial neoplasias(PanINs) arising in patients with chronic pancreatitis[J].Am J Surg Pathol, 2003, 27:1495-1501. doi: 10.1097/00000478-200312000-00001 [19] Karamitopoulou E, Zlobec I, Tornillo L, et al.Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia(PanIN) [J].Pathology, 2010, 42:229-234. http://www.ncbi.nlm.nih.gov/pubmed/20350215 [20] Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al.Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression[J].Cancer Res, 2000, 60:2002-2006. [21] Luttges J, Galehdari H, Brocker V, et al.Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis[J].Am J Pathol, 2001, 158:1677-1683. doi: 10.1016/S0002-9440(10)64123-5 [22] van Heek NT, Meeker AK, Kern SE, et al.Telomere shortening is nearly universal in pancreatic in traepithelial neoplasia[J].Am J Pathol, 2002, 161:1541-1547. doi: 10.1016/S0002-9440(10)64432-X [23] Ueki T, Toyota M, Sohn T, et al.Hypermethylation of multiple genes in pancreatic adenocarcinoma[J].Cancer Res, 2000, 60:1835-1839. http://gut.bmj.com/cgi/ijlink?linkType=ABST&journalCode=canres&resid=60/7/1835 [24] Park JY, Hong SM, Klimstra DS, et al.Pdx1 Expression in pancreatic precursor lesions and neoplasms[J].Appl Immunoh istochem Mol Morphol, (2011-02-10) [2011-03-02]. http://journals.lww.com/appliedimmunohist/Abstract/publishahead/Pdx1ExpressioninPancreaticPrecursorLesions.99685.aspx.doi:10.1097/PAI.0b013e318206d958 [25] Bausch D, Thomas S, Mino-Kenudson M, et al.Plectin-1 as a novel biomarker for pancreatic cancer[J].Clin Cancer Res, 2011, 15, 17:302-309. http://gut.bmj.com/cgi/ijlink?linkType=ABST&journalCode=clincanres&resid=17/2/302 [26] Yonezawa S, Higashi M, Yamada N, et al.Significance of mucin expression in pancreatobiliary neoplasms[J].J Hepatobiliary Pancreat Sci, 2010, 7:108-124. http://www.ncbi.nlm.nih.gov/pubmed/19787286 [27] Maitra A, Adsay NV, Argani P, et al.Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray [J].Mod Pathol, 2003, 16:902-912. doi: 10.1097/01.MP.0000086072.56290.FB [28] Haugk B.Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer? [J].Histopathology, 2010, 57: 503-514. doi: 10.1111/j.1365-2559.2010.03610.x [29] Brune KA, Abe T, Canto MI, et al.Multifocal neoplastic precusor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer[J].Am J Surg Pathol, 2006, 30:1067-1076. http://onlinelibrary.wiley.com/resolve/reference/PMED?id=16931950 [30] Jarboe EA, Layfield LJ.Cytologic features of pancreatic intraepithelial neoplasia and pancreatitis: potential pitfalls in the diagnosis of pancreatic ductal carcinoma[J].Diagn Cytopathol, (2010-08-20) [2011-03-02 ]. http://onlinelibrary.wiley.com/doi/10.1002/dc.21430. -
下载: 
点击查看大图
表(1)
计量
- 文章访问数: 575
- HTML全文浏览量: 258
- PDF下载量: 17
- 被引次数: 0
